Impact of Immune-Related Adverse Events on Melanoma Outcomes: A Comprehensive Analysis

Impact of Immune-Related Adverse Events on Melanoma Outcomes: A Comprehensive Analysis

Saved in:

Bibliographic Details
Main Authors:	Y. Ahmed, E. Finnegan, H. Ibrahim, D. Sabu
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001459
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma
by: Y. Ahmed, et al.
Published: (2024-01-01)

Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors
by: Juan I. Ruiz, et al.
Published: (2025-04-01)

The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment
by: Tianhang Zhang, et al.
Published: (2024-12-01)

Immune-related adverse events with adjuvant anti-PD-1 therapy in high-risk resected melanoma: a single-center experience
by: I. Csányi, et al.
Published: (2024-01-01)

Impact of Immunosenescence on Immune‐Related Adverse Events in Elderly Patients With Cancer
by: Jiayi Gao, et al.
Published: (2025-02-01)

Immunotherapy in Advanced Cutaneous Melanoma: From the Optimal Treatment Duration to the Impact on Survival in Case of Early Discontinuation Due to Immune-Related Adverse Events
by: Giacomo Triggiano, et al.
Published: (2025-04-01)

Predicting immune-related adverse events in patients with melanoma: the role of interleukin-7 rs16906115 polymorphism and lymphocyte dynamics
by: Fatma Pınar Açar, et al.
Published: (2025-06-01)

Hypercalcemia as an Immune-Related Adverse Event in a Patient Receiving Nivolumab and Ipilimumab for Metastatic Melanoma: A Case Report
by: Sam Plessers, et al.
Published: (2025-01-01)

Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
by: Diane van der Woude, et al.
Published: (2024-06-01)

Associations between immune-related adverse events and the effectiveness of immunotherapeutic agents in advanced melanoma: A systematic review and meta-analysis
by: Jiayang Yu, et al.
Published: (2025-04-01)

Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
by: D. Valančius, et al.
Published: (2021-12-01)

Strategies for improving the management of immune-related adverse events
by: James L Gulley, et al.
Published: (2020-10-01)

Immune Checkpoint Inhibitor-Related Sjögren’s Syndrome: An Ocular Immune-Related Adverse Event
by: Hideki Fukuoka, et al.
Published: (2025-05-01)

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
by: Min Li, et al.
Published: (2025-03-01)

Immune-related adverse events following checkpoint inhibitor treatment in head and neck cancers: A comprehensive review
by: Remi Kessler, et al.
Published: (2023-06-01)

Spontaneous haematoma: A unique immune-related adverse event alongside other cutaneous reactions in a patient treated with pembrolizumab for metastatic melanoma
by: Dalila Malek, et al.
Published: (2024-12-01)

Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
by: Lauren A Dalvin, et al.
Published: (2025-04-01)

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors
by: Jonathan L Curry, et al.
Published: (2025-08-01)

NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors
by: Michael S. Chang, MD, et al.
Published: (2025-02-01)

Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy
by: Arian Lasocki, et al.
Published: (2025-06-01)

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
by: Yuan Meng, et al.
Published: (2024-07-01)

Prevention and management of immune-related adverse events for biliary tract cancers
by: LIU Kun, GUO Wei
Published: (2025-03-01)

Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events
by: Min Kyu Kim, et al.
Published: (2024-11-01)

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
by: Chiara Cremolini, et al.
Published: (2023-01-01)

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
by: Alessandro Ceschi, et al.
Published: (2024-11-01)

Comprehensive analysis of adverse events associated with vortioxetine using the FDA adverse event reporting system
by: Liangxia Li, et al.
Published: (2025-05-01)

Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events
by: Tomoko Kobayashi, et al.
Published: (2024-01-01)

A systematic review of gastritis as an immune-related adverse event in clinical interventions
by: Fei Su, et al.
Published: (2024-12-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Tissue-resident memory T cells in immune-related adverse events: friend or foe?
by: Robin Reschke, et al.
Published: (2023-12-01)

Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use
by: Ko Kobayashi, et al.
Published: (2025-01-01)

Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events
by: Farees Saqlain, et al.
Published: (2020-01-01)

Tumor location as a risk factor for severe immune-related adverse events
by: Mike Wang, et al.
Published: (2025-05-01)

Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
by: Tappei Takada, et al.
Published: (2024-03-01)

Factors associated with adverse events following immunization in Albanian children: An analysis of the national database of adverse events after immunization
by: Irsida Mehmeti, et al.
Published: (2019-03-01)

Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events
by: Shadmehr Demehri, et al.
Published: (2025-05-01)

Improving the Monitoring of Adverse Events Following Immunization (in Order of Discussion)
by: N. I. Briko, et al.
Published: (2016-12-01)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
by: Maria Luisa De Perna, et al.
Published: (2025-08-01)

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors
by: Shaili Tapiavala, et al.
Published: (2025-08-01)